COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • April 14th, 2023 • Transcode Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 14th, 2023 Company Industry JurisdictionThis Common Stock Purchase Agreement (this “Agreement”) is entered into effective as April 13, 2023 (the “Execution Date”), by and between TransCode Therapeutics, Inc., a Delaware corporation, (the “Company”) and White Lion Capital LLC, a Nevada limited liability company (the “Investor”).